CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Halladay Benjamin Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-10-05 | Halladay Benjamin Chief Financial Officer | Grant or award · Restricted Stock Unit (RSU) | +200,000 | 200,000 | ||
| 2026-08-19 | Stewart Richard Alistair Director | Sale | −20,626 | $8.49 | $175K | 208,249 |
| 2026-07-27 | Sellig Thomas Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Sellig Thomas Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Martin Christopher Nathan Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Martin Christopher Nathan Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Royston Aaron Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Royston Aaron Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Waldman Reid Alexander Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Waldman Reid Alexander Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Stewart Richard Alistair Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Stewart Richard Alistair Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Farrow Jeffrey S Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Farrow Jeffrey S Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-07-27 | Phelan Nancy R. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-27 | Phelan Nancy R. Director | Grant or award · Restricted Stock Unit (RSU) | +16,700 | 16,700 | ||
| 2026-05-29 | Waldman Reid Alexander Director | Grant or award · Stock Option (right to buy) | +47,250 | 47,250 | ||
| 2026-05-29 | Farrow Jeffrey S Director | Grant or award · Stock Option (right to buy) | +47,250 | 47,250 | ||
| 2026-05-11 | Martin Christopher Nathan Director | Grant or award · Stock Option (right to buy) | +47,250 | 47,250 |
Page 1 of 36 · 715 trades